Form 4: DaVita Inc. Director Phyllis R. Yale Reports Acquisition of Shares

Director Phyllis R. Yale acquired 312 shares of DaVita Inc. common stock on November 15, 2024.

Summary

• Phyllis R. Yale, a director at DaVita Inc., reported acquiring 312 shares of common stock on November 15, 2024.
• The shares were acquired at a price of $0, which suggests they were likely granted as part of a compensation package.
• Following this transaction, Ms. Yale's total holdings in DaVita Inc. amount to 16,004 shares.

Sentiment

Score: 7

Explanation: The document reflects a routine insider transaction, which is generally neutral to positive. The acquisition of shares by a director can be seen as a sign of confidence.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It provides transparency into the ownership changes of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• Similar filings are made by directors and officers of companies like Fresenius Medical Care and Baxter International, which are also in the healthcare sector.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates director confidence in the company.

Key Dates

Keywords

DaVita Inc., Phyllis R. Yale, director, stock acquisition, Form 4, insider trading, share ownership